Saturday 17 October 2026
Export VSEED’s income statement to Excel — free account
VSee Health, Inc.
VSEED Healthcare Health Information Services
In the quarter to June 2026, revenue grew 48.0%, EPS grew 106.3%, free cash flow fell 257.6% and total debt rose 31.6%, each against the same quarter a year earlier.
1.88
0.01
−0.53%
Follow VSEED
| Older periods | Sep '25 | Dec '25 | Mar '26 | Jun '26 | |
|---|---|---|---|---|---|
P/E ratio |
+8 more quarters Free account |
0.00 | 0.00 | 0.00 | 0.00 |
P/S ratio |
0.01 | 0.01 | 0.01 | 0.01 | |
P/FCF ratio |
0.00 | 0.00 | 0.00 | 0.00 | |
P/Operating CF |
(0.17) | (0.05) | (0.06) | (0.14) | |
P/B ratio |
0.00 | 0.02 | 0.02 | 0.02 | |
Price to Tangible BV |
0.00 | 0.00 | 0.00 | 0.00 | |
EV/Sales |
0.02 | (0.30) | (0.03) | 0.03 | |
EV/EBITDA |
0.00 | 0.63 | 0.05 | 0.00 | |
EV/Operating CF |
(0.05) | 1.27 | 0.08 | (0.08) | |
EV/FCF |
(0.05) | 1.25 | 0.08 | (0.08) | |
Quick Ratio |
0.13 | 0.45 | 0.34 | 0.33 | |
Current Ratio |
0.16 | 0.52 | 0.41 | 0.40 | |
Net Debt/EBITDA |
(0.08) | 1.28 | 0.24 | (0.16) | |
Debt/Assets |
3.15% | 2.65% | 4.11% | 4.67% | |
Debt/Equity |
(0.11) | 0.11 | 0.12 | 0.10 | |
Asset Turnover |
0.55 | 0.69 | 0.75 | 0.86 | |
Operating CF/Net income |
2.60 | 0.25 | 0.94 | (1.39) | |
Capex/Depreciation |
(0.03) | (0.01) | (0.04) | 0.00 | |
Interest Coverage |
(2.72) | (3.75) | (26.30) | (33.42) | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
103.77% | 110.94% | 132.03% | 185.90% | |
Intangible Assets out of Total Assets |
0.76 | 0.61 | 0.69 | 0.75 | |
Share Based Compensation of Revenue |
0.00% | 5.76% | 13.96% | 12.97% | |
Graham Net Nets |
(162.94) | (92.26) | (52.47) | (36.50) | |
Graham Number |
340.37 | 0.00 | 0.00 | 0.00 | |
Earnings Yield |
(31,323.36%) | (15,783.78%) | (17,280.00%) | (24,666.67%) | |
Free Cash Flow Yield |
(3,594.83%) | (3,747.18%) | (3,685.84%) | (3,955.32%) | |
Revenue per Share |
19.24 | 24.86 | 5.28 | 1.16 | |
Operating CF per Share |
(3.65) | (7.65) | (4.10) | (0.87) | |
Capex per Share |
(0.11) | (0.03) | (0.04) | 0.00 | |
Free Cash Flow per Share |
(3.76) | (7.68) | (4.14) | (0.87) | |
Cash per Share |
2.29 | 20.06 | 2.25 | 0.34 | |
Shareholders Equity per Share |
(26.95) | 21.65 | 10.56 | 5.66 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
(26.95) | 21.65 | 10.56 | 5.66 | |
Free Cash Flow |
(0.78) | (1.93) | (2.48) | (1.17) | |
Working Capital |
(19.70) | (7.88) | (6.95) | (4.83) | |
Capital Expenditures |
(0.02) | (0.01) | (0.03) | — | |
Net Current Asset Value |
(20.56) | (8.60) | (7.85) | (5.88) | |
EV/EBIT |
0.00 | 0.46 | 0.04 | 0.00 | |
Capex to Sales |
0.01 | 0.00 | 0.01 | 0.00 | |
Price to Operating Income |
0.00 | 0.00 | 0.00 | 0.00 | |
| Other line items | |||||
Average Receivables |
2.60 | 1.98 | 2.26 | 1.92 | |
Average Payables |
9.99 | 9.34 | 8.99 | 8.01 | |
Average Assets |
21.87 | 21.20 | 19.21 | 17.47 | |
Average Common Equity |
(0.41) | 2.72 | 1.41 | 0.93 |
Columns are period end dates · fundamentals updated 2 Oct 2026